Cardiologist

Purpose

A cardiologist exists to keep blood moving and the pump that moves it from failing — to find the heart disease that kills quietly and the heart disease that kills in the next hour, and to tell them apart fast. The cardiovascular system is the one organ system where minutes of ischemia become permanent dead muscle and where a rhythm that looks unremarkable on a strip can drop a person dead at dinner. The cardiologist's reason for being is to read the heart's electrical and mechanical signals, estimate a person's risk of a future event that hasn't happened yet, and intervene early enough that it never does — while not subjecting the worried-well to procedures their hearts never needed.

Core Mission

Stratify each patient's cardiovascular risk honestly, treat the artery, the muscle, or the rhythm that threatens them most, and open the occluded vessel or correct the failing pump fast enough to save myocardium and life.

Primary Responsibilities

The visible work is reading ECGs and echoes and putting in stents; the actual work is risk arithmetic and timing. A cardiologist takes a cardiac history, auscultates and examines for the signs others miss, interprets the ECG against the clinical story, orders and reads echocardiograms, stress tests, and angiograms, and decides whether a chest pain is the artery, the muscle, the lining, or the esophagus. They manage chronic disease that never resolves — heart failure, atrial fibrillation, coronary disease — titrating drugs against blood pressure, heart rate, and renal function for years. They perform or refer for catheterization, ablation, and device implantation, and they own the long-term consequence of every anticoagulant they start. Underneath it all is the constant triage of the ischemic patient: is this the one whose vessel is closing right now?

Guiding Principles

• Time is muscle. In an occluded coronary, every minute of delay to reperfusion is myocardium that won't come back. The door-to-balloon clock is not a metric, it's the patient's ejection fraction in ten years.
• Stratify before you scan. The pretest probability of disease decides what the test means. A positive stress test in a low-risk 30-year-old is mostly a false positive; the same result in a diabetic smoker is a culprit lesion.
• Treat the patient's risk, not their cholesterol number. Statins help by absolute risk reduction; a high LDL in a low-risk person and a "normal" LDL in a post-MI patient call for opposite decisions.
• The ECG is interpreted with the patient, never alone. ST elevation in a pain-free athlete may be early repolarization; the same tracing with crushing pain is an artery to open now.
• Rate, rhythm, and anticoagulation are three separate decisions in AF. Don't conflate controlling the rate, restoring the rhythm, and preventing the stroke.
• The murmur is a question, the echo is the answer. Auscultate to know which valve to image, then quantify what your ears suspected.

Mental Models

• The ischemic cascade. Coronary supply-demand mismatch produces a fixed sequence: perfusion defect first, then diastolic then systolic dysfunction, then ECG changes, and only last the chest pain. This is why a stress echo or perfusion scan catches ischemia the resting ECG and the patient's symptoms miss — you're imaging an earlier rung of the ladder.
• Risk stratification as the organizing act. Framingham, ASCVD pooled-cohort, CHA2DS2-VASc for stroke, HAS-BLED for bleeding, GRACE and TIMI for acute coronary syndromes, the Wells-equivalent gestalt — every cardiology decision is a probability of a future event weighed against the cost of preventing it.
• Preload, afterload, contractility (the Frank-Starling and pressure-volume view). Heart failure management is hemodynamics: is this patient wet or dry, warm or cold? The four quadrants dictate diuretics, vasodilators, or inotropes.
• Supply and demand. Angina is the heart asking for more oxygen than the narrowed artery can deliver. You can open the supply (revascularize) or lower the demand (beta-blockade, rate control) — and stable disease often does better with the latter.
• Reentry vs. automaticity vs. triggered activity. Arrhythmias are not one thing; the mechanism dictates whether you ablate a circuit, suppress a focus, or fix the metabolic trigger.
• The vulnerable plaque, not the tight stenosis. Most MIs come from rupture of a non-flow-limiting plaque, not the 90% lesion the angiogram shows. This is why stenting stable lesions doesn't prevent infarcts the way statins and antiplatelets do.

First Principles

• A coronary either has enough flow for the demand placed on it or it doesn't; everything else is detail.
• Dead myocardium does not regenerate; the entire urgency of acute cardiology is about preventing necrosis, not reversing it.
• Every antithrombotic that prevents a clot also causes a bleed; the art is the net.
• The heart fails forward and backward; symptoms tell you which side and which filling pressure.
• A rhythm is only dangerous in the context of the heart it's beating in.

Questions Experts Constantly Ask

• Is this an acute coronary syndrome until proven otherwise, and what's the time from symptom onset?
• What is this patient's actual event risk over the next ten years, not just their numbers today?
• Will revascularizing this lesion change the patient's symptoms or survival, or only the angiogram?
• Is this heart failure preserved or reduced ejection fraction — because the evidence base diverges sharply?
• What's the CHA2DS2-VASc, what's the bleeding risk, and does the net favor anticoagulation?
• Is this syncope benign vasovagal or the herald of sudden cardiac death?

Decision Frameworks

• STEMI vs. NSTEMI vs. unstable angina. ST elevation means a vessel is occluded now: activate the cath lab, door-to-balloon under 90 minutes. NSTEMI is risk-stratified (GRACE) to early-invasive or conservative. The ECG and troponin trajectory drive the tempo.
• Revascularize vs. optimize medically. For stable coronary disease, COURAGE and ISCHEMIA say medical therapy matches PCI for survival; intervene for refractory symptoms or high-risk anatomy (left main, three-vessel with low EF), where CABG often beats stents.
• Rate vs. rhythm control in AF. AFFIRM showed no survival difference for most; rhythm control for the symptomatic or the young, rate control for the tolerant elderly — but anticoagulation is decided separately by stroke risk.
• Heart failure GDMT. In reduced EF, layer the four pillars — ARNI, beta-blocker, MRA, SGLT2 inhibitor — titrated to target doses, because each reduces mortality and the benefit is additive.

Workflow

1. Triage the chest pain. ECG within 10 minutes, troponin, and the gestalt: is the artery closing now? STEMI bypasses everything to the cath lab.
2. History and exam. Characterize the symptom, the risk factors, the functional capacity; auscultate for the murmur, gallop, and rub.
3. Stratify risk. Apply the relevant score; estimate pretest probability before choosing a test.
4. Image and test selectively. ECG, echo for structure and function, stress for inducible ischemia, angiography when the probability is high enough to act.
5. Decide the intervention. Medical optimization, revascularization, ablation, or device — matched to the mechanism and the evidence.
6. Titrate and monitor. Up-titrate GDMT against pressure, rate, potassium, and creatinine; recheck the echo to see if the muscle recovered.
7. Follow for life. Coronary disease, heart failure, and AF are chronic; adjust as renal function, rhythm, and the patient's goals change.

Common Tradeoffs

• Antiplatelet/anticoagulant potency vs. bleeding. Dual antiplatelet therapy and DOACs prevent thrombosis and cause hemorrhage; duration and intensity are a net-benefit calculation per patient.
• PCI now vs. CABG durability. Stents are faster and less invasive; bypass is more durable in diabetics and complex disease. The Heart Team decides.
• Rate control simplicity vs. rhythm control symptom relief. Restoring sinus feels better but carries procedural and drug risk.
• Aggressive diuresis vs. renal perfusion. Drying out the congested patient relieves dyspnea but can tip the kidneys into injury.
• Detecting disease early vs. overdiagnosis. Coronary calcium scoring and troponin sensitivity catch real disease and a flood of borderline findings that drive anxiety and downstream testing.

Rules of Thumb

• New ST elevation with pain is a STEMI until an expert says otherwise — call the lab, don't wait for troponin.
• A troponin that's rising is more dangerous than one that's high and flat.
• Treat the patient who looks like they're in pulmonary edema before the chest film confirms it.
• Syncope during exertion or while supine is cardiac until excluded; syncope standing in a hot church usually isn't.
• A new murmur with fever is endocarditis until echo and cultures say no.
• Don't start an antiarrhythmic without thinking about the QT and the proarrhythmia you might cause.
• If the echo and the symptoms disagree, re-examine the patient and repeat the echo before chasing a third test.

Failure Modes

• Anchoring on the atypical-pain bias. Calling a real ACS "atypical" and discharging it, especially in women and diabetics whose presentations differ.
• Oculostenotic reflex. Stenting every lesion you see on the angiogram because it's there, not because it's causing ischemia (skip the FFR/iFR).
• Forgetting anticoagulation is a separate decision in AF. Controlling the rate and leaving the patient unprotected from stroke.
• Under-titrating heart failure therapy. Starting the four pillars at low dose and never reaching the doses that reduced mortality in the trials.
• Chasing the troponin without the story. Treating a demand-ischemia troponin bump in sepsis as if it were a coronary occlusion.
• Ignoring the right ventricle. Tunnel vision on the left heart while the RV fails in PE or inferior MI.

Anti-patterns

• Stenting stable single-vessel disease for prognosis when the evidence says it only treats symptoms.
• The reflexive stress test in someone whose pretest probability is so low or so high the result won't change management.
• Polypharmacy without deprescribing in the elderly, where the regimen causes more falls and bleeds than the disease.
• Reading the ECG without the patient and over-calling benign variants.
• Treating diastolic dysfunction with the systolic playbook, applying reduced-EF drugs to preserved-EF physiology where they don't help.

Vocabulary

• STEMI / NSTEMI — heart attack with / without ST-segment elevation, the divide that sets reperfusion urgency.
• Ejection fraction — the percent of blood the left ventricle ejects per beat; the core measure of systolic function.
• Ischemia vs. infarction — reversible oxygen starvation vs. irreversible muscle death.
• Door-to-balloon time — minutes from arrival to opening the occluded artery.
• CHA2DS2-VASc / HAS-BLED — the stroke-risk and bleeding-risk scores in AF.
• GDMT — guideline-directed medical therapy, the mortality-reducing drug regimen.
• FFR / iFR — fractional flow reserve; whether a stenosis actually limits flow.
• Regurgitation / stenosis — a valve that leaks vs. one that won't open.
• Inotropy / chronotropy — contractile force vs. heart rate.

Tools

• The 12-lead ECG — the fastest, cheapest window on ischemia and rhythm.
• Echocardiography — bedside imaging of structure, function, and valves; the cardiologist's stethoscope made visible.
• Cardiac catheterization and angiography — the definitive coronary map and the route to PCI.
• Stress testing (exercise, nuclear, stress echo) — provoking the ischemic cascade to reveal flow-limiting disease.
• Cardiac MRI and CT angiography — tissue characterization and non-invasive coronary anatomy and calcium burden.
• Implantable devices (pacemakers, ICDs, CRT) — pacing the slow heart, defibrillating the lethal rhythm, resynchronizing the failing one.

Collaboration

Cardiology runs on a Heart Team. The interventional cardiologist and the cardiac surgeon jointly decide PCI versus CABG for complex disease; treating either as the default is how patients get the wrong operation. The electrophysiologist owns the ablations and devices. Cardiac nurses and the cath-lab team execute the time-critical STEMI choreography where seconds count. The cardiologist consults to the emergency physician at the front door and to the intensivist for the patient in cardiogenic shock, and works with the anesthesiologist for procedural sedation and pre-operative cardiac risk clearance. The recurring friction is the chest pain handoff: the discipline is to communicate the troponin trajectory and the ECG evolution, not just a label.

Ethics

Cardiology sits where a procedure can save a life and where the same procedure, done for the wrong indication, carries a financial incentive the patient can't see. The honest cardiologist refuses to stent a lesion that won't help the patient because the cath lab is profitable. Informed consent for anticoagulation means the patient understands they are trading a stroke risk for a bleed risk and gets to weigh it. End-of-life cardiology is its own hard ground: deactivating an ICD in a dying patient so they aren't shocked in their final hours, declining the fourth revascularization in advanced heart failure, and being honest that an LVAD or transplant has its own grueling course. The duty is to name the patient's real prognosis rather than offer one more procedure as a way of avoiding the conversation.

Scenarios

The 58-year-old diabetic with "indigestion." She describes epigastric burning and nausea for an hour, no classic chest pain, and wants to go home. The trap is the atypical-presentation bias that misses MIs in women and diabetics. The ECG shows subtle ST depression in the lateral leads; the first troponin is borderline. The expert does not discharge. GRACE puts her at intermediate-high risk, so the plan is early-invasive: serial troponins rise, angiography shows a critical circumflex lesion, and PCI reopens it. The discipline that saved her was refusing to let an atypical story close a high-stakes differential.

The asymptomatic 90% LAD lesion found on a stress test. A stable patient with controlled angina has a tight proximal LAD on angiography. The reflex — the oculostenotic reflex — is to stent it. The expert measures FFR, which comes back 0.85, meaning the lesion isn't flow-limiting. ISCHEMIA and COURAGE say stenting won't improve his survival or, with mild symptoms, his life. The decision is to optimize medical therapy: high-intensity statin, antiplatelet, beta-blocker, and risk-factor control. Leaving the stent on the shelf is the skilled act.

New atrial fibrillation in an 82-year-old after a fall. He's in AF at 130, asymptomatic at rest. Three decisions, kept separate: rate control with a beta-blocker brings him to 80; rhythm control is deferred because he's tolerant and elderly (AFFIRM); and anticoagulation is decided on its own — CHA2DS2-VASc of 5 strongly favors a DOAC, but he has a recent fall and a HAS-BLED of 3. The expert doesn't reflexively withhold the anticoagulant for fall risk (the stroke he'd prevent outweighs the bleed from falls) but does treat the fall risk and choose the agent and dose accordingly.

Related Occupations

A cardiologist is a physician who specialized in the heart, so internal medicine is the foundation the discipline is built on. Cardiac surgeons resolve coronary and valve disease with the knife where catheters can't reach, and the two decide together. Emergency physicians compress the same acute-coronary reasoning into the first minutes at the front door. Radiologists share the interpretation of cardiac CT and MRI. Anesthesiologists partner on procedural sedation and pre-operative cardiac risk. The registered nurse in the cath lab and CCU is the cardiologist's continuous eyes on the unstable patient.

References

• Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine
• Harrison's Principles of Internal Medicine (cardiovascular section)
• ACC/AHA Clinical Practice Guidelines
• The ESC Textbook of Cardiovascular Medicine
• Marriott's Practical Electrocardiography